Follow-up documentation. Uveitis-related eye complications per patient, n (%) | Group I. Uveitis, ANA-positive, no JIA, N = 56 | Group II. Uveitis manifestation after JIA disease onset*, N = 56 | Group III. Uveitis manifestation before JIA disease onset*, N = 37 | p value†| Significant pairwise comparisons‡ | |||
---|---|---|---|---|---|---|---|---|
 | N | % | N | % | N | % |  |  |
Any complication | 29 | 56.9 | 20 | 37.7 | 19 | 57.6 | 0.086 | Â |
Band keratopathy | 7 | 13.7 | 2 | 3.8 | 9 | 27.3 | 0.072 | II vs. III |
Glaucoma | 4 | 7.8 | 0 | 0.0 | 0 | 0.0 | 0.031 | Â |
Synechiae | 16 | 31.4 | 13 | 24.5 | 11 | 33.3 | 0.622 | Â |
Ocular hypotony | 0 | 0.0 | 0 | 0.0 | 2 | 6.1 | 0.041 | Â |
Retinal detachment | 1 | 2.0 | 0 | 0.0 | 1 | 3.0 | 0.500 | Â |
Papille edema | 3 | 5.9 | 2 | 3.8 | 2 | 6.1 | 0.852 | Â |
Iris rubeosis | 3 | 5.9 | 0 | 0.0 | 1 | 3.0 | 0.205 | Â |
Cataract | 10 | 19.6 | 5 | 9.4 | 6 | 18.2 | 0.309 | Â |
Vitreous opacities | 5 | 9.8 | 4 | 7.6 | 2 | 6.1 | 0.816 | Â |
Macular edema | 2 | 3.9 | 2 | 3.8 | 1 | 3.0 | 0.976 | Â |
Amblyopia/strabism | 3 | 5.9 | 0 | 0.0 | 2 | 6.1 | 0.194 | Â |
Other complications | 2 | 3.9 | 5 | 9.4 | 3 | 9.1 | 0.503 | Â |
Treatment-related eye complications | 1 | 2.0 | 1 | 1.9 | 1 | 3.0 | 0.931 | Â |